全文获取类型
收费全文 | 5973篇 |
免费 | 470篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 100篇 |
儿科学 | 88篇 |
妇产科学 | 105篇 |
基础医学 | 676篇 |
口腔科学 | 32篇 |
临床医学 | 563篇 |
内科学 | 1333篇 |
皮肤病学 | 64篇 |
神经病学 | 472篇 |
特种医学 | 401篇 |
外科学 | 1214篇 |
综合类 | 78篇 |
一般理论 | 2篇 |
预防医学 | 454篇 |
眼科学 | 90篇 |
药学 | 377篇 |
中国医学 | 7篇 |
肿瘤学 | 451篇 |
出版年
2023年 | 78篇 |
2022年 | 105篇 |
2021年 | 248篇 |
2020年 | 121篇 |
2019年 | 208篇 |
2018年 | 240篇 |
2017年 | 147篇 |
2016年 | 147篇 |
2015年 | 180篇 |
2014年 | 247篇 |
2013年 | 309篇 |
2012年 | 460篇 |
2011年 | 453篇 |
2010年 | 255篇 |
2009年 | 222篇 |
2008年 | 321篇 |
2007年 | 372篇 |
2006年 | 343篇 |
2005年 | 299篇 |
2004年 | 285篇 |
2003年 | 243篇 |
2002年 | 203篇 |
2001年 | 50篇 |
2000年 | 59篇 |
1999年 | 66篇 |
1998年 | 54篇 |
1997年 | 70篇 |
1996年 | 34篇 |
1995年 | 39篇 |
1994年 | 26篇 |
1993年 | 19篇 |
1992年 | 30篇 |
1991年 | 30篇 |
1990年 | 23篇 |
1989年 | 30篇 |
1988年 | 35篇 |
1987年 | 44篇 |
1986年 | 40篇 |
1985年 | 32篇 |
1984年 | 19篇 |
1983年 | 15篇 |
1982年 | 21篇 |
1981年 | 18篇 |
1979年 | 34篇 |
1978年 | 27篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1975年 | 15篇 |
1974年 | 14篇 |
1971年 | 9篇 |
排序方式: 共有6507条查询结果,搜索用时 15 毫秒
1.
Itay Zmora Yonit Wiener-Well Evan Avraham Alpert 《The American journal of emergency medicine》2019,37(5):1006.e5-1006.e7
Background
Purulent bacterial pericarditis is a rare and potentially fatal disease. The course may be fulminant, and the presentation may pose a diagnostic challenge.Case report
An otherwise healthy 75-year-old male was brought to the emergency department in a state of general deterioration, confusion, and shock. Bedside ultrasound showed a significant pericardial effusion. His condition quickly deteriorated and the resuscitation included emergent bedside pericardiocentesis. The drainage was purulent and later cultures grew out Streptococcus pneumoniae.Why should an emergency physician be aware of this?
Purulent pericarditis is extremely rare but should be considered in the patient with a fulminant infectious process (particularly pneumonia) and signs of pericardial effusion. Treatment should include appropriate antibiotics and early drainage. 相似文献2.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
3.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献4.
5.
6.
7.
8.
9.
We evaluated 162 high risk male patients for the presence of subclinical anogenital human papillomavirus infection with magnified penile surface scanning. Infected patients were treated as outpatients with the carbon dioxide laser under local anesthesia. Of the patients 43 were followed for a mean of 8.7 months or 2.1 treatments after the initial treatment (range 3 to 30 months). A subset of 10 patients was followed for more than 20 months or 6.2 treatments. To date a 51% recurrence rate has been observed in the over-all population and a 50% recurrence rate was noted in the 20-month followup population. In a separate arm of this study a small number of patients (15) with deoxyribonucleic acid typed subclinical intraurethral disease plus subclinical skin lesions were treated with topical carbon dioxide laser therapy for the penile lesions and adjuvant intraurethral 5% 5-fluorouracil. Mean followup in the group was approximately 4 months. The addition of intraurethral therapy in this positive human papillomavirus reservoir group had no significant effect on the high rate of human papillomavirus recurrence. 相似文献
10.
Angel J. Amante Herwig-Ulf Meier-Kriesche Linda Schoenberg B. D. Kahan 《Transplant international》1997,10(3):217-222
The initial poor absorption of the corn oil-based, gel capsule oral formulation of cyclosporin (CyA) greatly limits its use
for inception of immunosuppressive therapy. Insufficient drug concentrations during the early post-transplant period predispose
to renal allograft rejection. The present study served to compare the time required to achieve therapeutic CyA concentrations
after de novo administration of the corn oil-based gel capsule (CyA-GC; n = 11) versus the microemulsion (CyA-ME; n = 11) formulation of CyA. During the 1st month after renal transplantation, patients underwent serial pharmacokinetic profiling
from which we obtained observed and dose-corrected values of several parameters. Although patients in neither the CyA-GC nor
the CyA-ME group adequately absorbed the drug during days 0–2, from day 3 to 4 patients in the CyA-ME group showed significantly
greater absorption than those in the CyA-GC group (P = 0.041). Patients in the CyA-ME group reached the 1st month target average concentration (Cav) values ( ≥ 550 ng/ml) earlier than those in the CyA-GC group and required significantly lower daily CyA doses (P = 0.018). We conclude that therapeutic CyA levels can be achieved more rapidly and with lower doses of the drug after de
novo administration of CyA-ME than with CyA-GC.
Received: 13 September 1996 Accepted: 7 January 1997 相似文献